LARGE1 (AA 35-142) 抗体
Our Local Distributor
北京 101111
Quick Overview for LARGE1 (AA 35-142) 抗体 (ABIN2749093)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 35-142
-
原理
- Anti-LARGE1 Purified
-
特异性
- The mouse monoclonal antibody LARGE-02 recognizes human LARGE1, a glycosyltransferase expressed mainly in the Golgi apparatus. Crossreactivity with LARGE2 was not determined.
-
交叉反应 (详细)
- Human
-
纯化方法
- Purified by protein-A affinity chromatography.
-
纯度
- > 95 % (by SDS-PAGE)
-
免疫原
- Recombinant fragment of human LARGE1 (amino acids 35-142)
-
亚型
- IgG2b
-
-
-
-
应用备注
- Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- Store at 2-8°C. Do not freeze.
-
-
- LARGE1
-
背景
- LARGE xylosyl- and glucuronyltransferase 1,LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.,Xysosyl- and glucosyl transferase 1
-
基因ID
- 9215
-
UniProt
- O95461
抗原
-